Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...

New York City’s housing shortage may find an unlikely hero in its glut of underused office buildings, according to Brad ...

Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

Key Points Pfizer stands as one of the largest pharmaceutical companies in the world.Although it has an attractive 7.1% yield, it has a big blemish in its dividend past.Investors looking at drug ...

You can buy shares of Healthpeak Properties and Pfizer with well less than $100 at the moment. At the moment, anyone with ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Pfizer Inc. (NYSE:PFE) hasn’t ...

Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...

Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...

The Bristol Myers Squibb-Pfizer Alliance today announced a new direct-to-patient option for purchasing Eliquis (apixaban) via ...